- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Purple Biotech Stock (NASDAQ:PPBT), Quotes and News Summary
Purple Biotech Stock (NASDAQ: PPBT)
| Day Range2.09 - 2.23 | 52 Wk Range1.83 - 4.36 | Open / Close2.13 / 2.14 | Float / Outstanding- / 18.3M |
| Vol / Avg.17.9K / 85.7K | Mkt Cap38.8M | P/E- | 50d Avg. Price2.33 |
| Div / Yield- | Payout Ratio- | Total Float- | EPS-0.2 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-18 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.200 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Purple Biotech Questions & Answers
You can purchase shares of Purple Biotech (NASDAQ: PPBT) through any online brokerage.
Other companies in Purple Biotech’s space includes: Opiant Pharma (NASDAQ:OPNT), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Ocuphire Pharma (NASDAQ:OCUP) and Lipocine (NASDAQ:LPCN).
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by Chardan Capital on Thursday, September 8, 2022. The analyst firm set a price target for 11.00 expecting PPBT to rise to within 12 months (a possible 418.87% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Purple Biotech (NASDAQ: PPBT) is $2.12 last updated October 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Purple Biotech.
Purple Biotech’s Q3 earnings are confirmed for Friday, November 18, 2022.
There is no upcoming split for Purple Biotech.
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.